Triplet Induction + 1 or 2-Drug Maintenance
A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sort by
Anchorage Associates in Radiation Medicine
Anchorage, AK
- Accepting patients
Anchorage Radiation Therapy Center
Anchorage, AK
- Accepting patients
Alaska Breast Care and Surgery LLC
Anchorage, AK
- Accepting patients
Alaska Oncology and Hematology LLC
Anchorage, AK
- Accepting patients
Alaska Women's Cancer Care
Anchorage, AK
- Accepting patients
Anchorage Oncology Centre
Anchorage, AK
- Accepting patients
Katmai Oncology Group
Anchorage, AK
- Accepting patients
Providence Alaska Medical Center
Anchorage, AK
- Accepting patients
Cancer Center at St. Joseph's
Phoenix, AZ
- Accepting patients
Mercy Hospital Fort Smith
Fort Smith, AR
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.